论文部分内容阅读
1928年Lohman发明了ATP,并因其具有高能量化合物的功能和扩张脑血管、冠状血管的作用而应用于临床。在欧洲自五十年代始用于小儿的阵发性室上性心动过速(PSVT)的治疗。近年来,报道ATP治疗PSVT的文献逐渐增多。认为其有效率与异搏定相似,达90％以上,较洋地黄为高(61-71％),但转复时间比异搏定和洋地黄快。虽副作用发生率高,可较异搏定和洋地黄轻,持续时间短,仅数
In 1928 Lohman invented ATP and is used clinically because of its function as a high-energy compound and the expansion of cerebrovascular and coronary vessels. Treatment of paroxysmal supraventricular tachycardia (PSVT) in children in Europe since the 1950s. In recent years, reports of ATP treatment of PSVT literature gradually increased. It is believed that its effectiveness is similar to verapamil, reaching more than 90%, higher than that of digitalis (61-71%), but the recovery time is faster than verapamil and digitalis. Although the high incidence of side effects, compared with verapamil and digitalis light, short duration, only a few